Stem-cell transplantation for chronic lymphocytic leukemia: The 1999 perspective

Annals of Oncology

Volumn 11, Issue SUPPL. 1, 2000, Pages

  Dreger, P ^b   Michallet, M ^a   Schmitz, N ^c  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b Second Department of Medicine   (Germany)

^c NONE

Author keywords

CLL; Prognosis; Stem cell transplantation; Therapy

Indexed keywords

ALLOTRANSPLANTATION; AUTOTRANSPLANTATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; CONFERENCE PAPER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 0033994848     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/11.suppl_1.S49     Document Type: Conference Paper

References (21)

1. Dreger P, Schmitz N. The role of stem-cell transplantation in the treatment of chronic lymphocytic leukemia. Leukemia 1997: 11: S42-5.
2. Michallet M, Archimbaud E, Roulings PA et al. HLA-identical sibling bone-marrow transplants for chronic lymphocytic leukemia. Ann Intern Med 1996; 124: 311-5.
3. Michallet M, Carreras E, Cornelissen JJ et al. Allotransplants and autotransplants in CLL. Bone Marrow Transplant 1999; 23 (Suppl 1): S53 (Abstr).
4. Gratwohl A, Passweg J, Baldomero H et al. Blood and marrow transplantation activity in Europe 1996. European Group for Blood and Marrow Transplantation (EBMT). BMT 1998; 22: 227-40.
5. Khouri IF, Keating M, Korbling M et al. Transplant-lite: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol 1998; 16: 2817-24.
6. McSweeney PA, Wagner J, Maloney DG et al. Blood 1998; 92 (Suppl 1): 519a (Abstr).
7. Khouri IF, Przepiorka D, van BK et al. Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: Timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease. Br J Haematol 1997; 97: 466-73.
8. Pavletic ZS, Arrowsmith ER, Bierman P et al. Allogeneic stem-cell transplantation from related or unrelated donors for B-CLL. Blood 1998; 92: 288a (Abstr).
9. Dreger P, von Neuhoff N, Kuse R et al. Early stem-cell transplantation for chronic lymphocytic leukaemia: A chance for cure? Br J Cancer 1998; 77: 2291-7.
10. Esteve J, Villamor N, Colomer D et al. Hematopoietic stem-cell transplantation in chronic lymphocytic leukemia: A report of 12 patients from a single institution. Ann Oncol 1998; 9: 167-72.
11. Gribben JG, Neuherg D, Soiffer RJ et al. Autologous versus allogeneic bone marrow transplantation for patients with poor-prognosis CLL. Blood 1998; 92: 322a (Abstr).
12. Pavletic ZS, Biermann PJ, Vose JM et al. High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small-lymphocytic lymphoma. Ann Oncol 1999; 9: 1023-6.
13. Milligan DW, Davies FE, Morgan GJ et al. Fludarabine followed by stem-cell autografting for younger patients with CLL: Preliminary results from the MRC pilot study. BMT 1999; 23 (Suppl 1): S53 (Abstr).
14. Proia A, Mauro F, Capria S et al. Fludarabine therapy followed by unmanipulated PBSCT: A single-center experience on 20 CLL patients. Bone Marrow Transplant 1999; 23 (Suppl 1): S54 (Abstr).
15. Scime R, Indovina A, Santoro A et al. PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemia. BMT 1998; 22: 1159-65.
16. Michallet M, Apperley J. Peripheral blood progenitor cell mobilisation and transplantation after fludarabine therapy in chronic lymphocytic leukemia in Europe. BMT 1997: 19 (Suppl 1): S146 (Abstr).
17. Dreger P, Viehmann K, von Neuhoff N et al. Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: A prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery. BMT 1999; 23 (in press).
18. Paulus U, Schmitz N, Viehmann K et al. Combined positive negative selection for highly-effective purging of PBPC grafts: Towards clinical application in patients with B-CLL. BMT 1997; 20: 415-20.
19. Provan D, Bartlett-Pandite L, Zwicky C et al. Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone-marrow transplantation. Blood 1996; 88: 2228-35.
20. Donnovan JW, Andersen NS, Poor CM et al. Prospective analysis of minimal residual disease detection in patients with CLL undergoing autologous and allogeneic BMT. Blood 1998; 92: 652a (Abstr).
21. von Neuhoff N, Schmitz N, Suttorp M et al. Detection of minimal residual disease after stem-cell transplantation for chronic lymphocytic leukemia by clone-specific oligonucleotides. Blood 1998; 92: 652a (Abstr).